Lynn E. Rinkema - Concepedia

Author

Lynn E. Rinkema

Eli Lilly (United States)

Also Known As

L E Rinkema, L. E. RINKEMA, L. E. Rinkema, L. Rinkema, LYNN E. RINKEMA, Lynn E Rinkema, Lynn E. Rinkema, Lynn Rinkema

Publications

723

Citations

H-Index

Concepts

All Affiliations

Eli Lilly (United States)Loyola University Chicago

About

Lynn E. Rinkema is an author at Eli Lilly (United States) specializing in medicine, physiology, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	12	274
2	Natural Sciences	5	5	79
3	Public Health	2	2	23
4	Social Sciences	2	2	45
5	Anesthesia	2	2	32

Lynn E. Rinkema

Publications

697

Citations

H-Index

Page 1

	Year	Citations
LY171883, 1-less than 2-hydroxy-3-propyl-4-less than 4-(1H-tetrazol-5-yl) butoxy greater than phenyl greater than ethanone, an orally active leukotriene D4 antagonist. J H Fleisch, Lynn E. Rinkema, Klaus D. Haisch, Journal of Pharmacology and Experimental Therapeutics	1985	163
Evidence for multiple leukotriene D4 receptors in smooth muscle Jerome H. Fleisch, Lynn E. Rinkema, Stephen Baker Life Sciences Muscle FunctionMolecular PhysiologyMedicinePhysiologyReceptor (Biochemistry)	1982	91
Leukotriene receptor antagonists. 1. Synthesis and structure-activity relationships of alkoxyacetophenone derivatives Winston S. Marshall, Theodore Goodson, George J. Cullinan, Journal of Medicinal Chemistry	1987	67
Production and antagonism of cutaneous vascular permeability in the guinea pig in response to histamine, leukotrienes and A23187. Lynn E. Rinkema, Kerry G. Bemis, J H Fleisch Journal of Pharmacology and Experimental Therapeutics	1984	51
Cardiovascular effects of the macrolide antibiotic tilmicosin, administered alone and in combination with propranolol or dobutamine, in conscious unrestrained dogs Bradley W. Main, Jeffrey R. Means, Lynn E. Rinkema, Journal of Veterinary Pharmacology and Therapeutics	1996	44
Pharmacologic receptors for the leukotrienes Jerome H. Fleisch, Lynn E. Rinkema, Winston S. Marshall Biochemical Pharmacology InflammationMedicineImmunologyReceptor (Biochemistry)Pharmacological Agent	1984	38
Functional characterization of atrial pacemaker activity W. C. Randall, Lynn E. Rinkema, Stephanie B. Jones, American Journal of Physiology-Heart and Circulatory Physiology Cardiac MuscleElectrophysiological EvaluationAtrial Pacemaker ActivityNeurophysiologyPhysiology	1982	26
Leukotriene receptor antagonists. 2. The [[(tetrazol-5-ylaryl)oxy]methyl]acetophenone derivatives Robert D. Dillard, F. Patrick Carr, Doris McCullough, Journal of Medicinal Chemistry Molecular PharmacologyMedicinal ChemistryPharmacological StudyBiochemistryMedicine	1987	24
Evaluation of LY203647 on cardiovascular leukotriene D4 receptors and myocardial reperfusion injury. R Hahn, Brian MacDonald, Elizabeth N. Morgan, Journal of Pharmacology and Experimental Therapeutics	1992	23
Pharmacologic analysis of two novel inhibitors of leukotriene (slow reacting substance) release. J H Fleisch, Klaus D. Haisch, Stephen M. Spaethe, Journal of Pharmacology and Experimental Therapeutics	1984	19

Page 1